Key facts
- Notable investors include Cambridge Innovation Center, Fortify Ventures, LabCentral, MIT Delta V, Play Money — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for LymeAlert
- ·The full record, as it builds
Funding rounds
No funding rounds for LymeAlert are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LymeAlert
Developer of an at-home tick testing kit designed to help people identify potential Lyme disease risk quickly after a tick is found on a person or animal. The company offers an easy-to-use test that works on live or dead ticks, supports testing multiple ticks from a single kit, and delivers quick visual results, enabling individuals, pet owners, and animal caregivers to make informed decisions and seek care sooner when risk is detected.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2024
- Employees
- 10
- Website
- lymealert.com/
- Ownership
- Privately Held (backing)
LymeAlert doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LymeAlert shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LymeAlert in its N-PORT filings yet. We sweep new filings monthly.